Anzeige
Mehr »
Login
Montag, 29.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Fokus auf Nurexone: High-Level Biotech im Pennystock-Kleid!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
234 Leser
Artikel bewerten:
(0)

Groundbreaking eCTD Workstation Solution from LORENZ Life Sciences Group

PHILADELPHIA, Dec. 18, 2012 /PRNewswire/ --LORENZ Life Sciences Group launched today their groundbreaking new offering in the US market - docuBridge ONE, the eCTD Workstation Solution.

docuBridge ONE is a token-based, single user eSubmission solution downloadable to a user's workstation from www.lorenz.cc in less than five minutes."The eCTD expertise we have amassed through having LORENZ docuBridge used in hundreds of companies spanning the globe is now packaged as an affordable option for the ad-hoc eCTD publisher," said Yaprak Eisinger, MD North America, who has already been informed by a number of interested companies that they intend to begin making online purchases to pilot docuBridge ONE before the end of 2012.

Industry experts are impressed and excited by the opportunities dB ONE will bring to the world of electronic submissions. "With docuBridge ONE, LORENZ has set a Life Sciences industry benchmark for eCTD software affordability, ease of installation, and access to high-quality support. docuBridge ONE is groundbreaking for those life sciences companies needing a cost effective solution for their eCTD publishing challenges. I intend to recommend dB ONE for all my clients who want to control their eCTD submissions," said Antoinette Azevedo, President & CEO of esubmissionssolutions.com.

Announced in October at both the DIA "EDM and ERS/eCTD" and the 2012 RAPS "The Regulatory Convergence" conferences, docuBridge ONE was hailed as the long-awaited solution by enthusiastic regulatory professionals conceptualizing the solution's many potential markets: consultants and CROs who like its "pay-as-you go" with a token approach and small companies who can't afford to make a large upfront investment when they have not yet built the infrastructure for eSubmission.

David Zuchero, President, Chesapeake Regulatory Group, Inc., an ideal customer for docuBridge ONE, said, "CRG is a regulatory affairs consulting firm that's been in business for over 20 years. For a number of years I've been looking for a cost-effective way to provide electronic submission services to our clients. After demoing docuBridge ONE I think we've found the solution. docuBridge ONE looks like a great eSubmission solution for smaller service providers like us, without a significant upfront investment. We're looking forward to the launch of dB ONE and the opportunity to provide this service to all of our clients."

"LORENZ made a substantial investment to bring docuBridge ONE to market with such ease of use and secure payment capabilities," said Wolfgang Witzel, President of LORENZ Life Sciences Group, adding that "Customers need to feel safe when they use their credit cards to purchase docuBridge ONE tokens or support hours. We created a secure infrastructure, allocated dedicated docuBridge ONE support staff and designed e-learning modules - all to make LORENZ docuBridge simple and affordable to the average 'Joe the Publisher.'"

For more information on dB ONE, visit: http://www.lorenz.cc/eSolutions/docuBridge-one or call 1 866 9LORENZ - 1 866 956 7369.

About LORENZ Life Sciences Group LORENZ Life Sciences Group (www.lorenz.cc) has been developing and marketing software solutions for the Life Sciences market since 1989. LORENZ's solutions are geared specifically for submission assembly, review, publishing, validation and management. As the number one supplier of submission management systems in the world, as well as the largest supplier of eCTDs for U.S., European and Japanese submissions in the world, LORENZ is the technological market leader. With over 250 installations in 25 countries, LORENZ has built a reputable customer base. For more information, please click www.lorenz.cc.

SOURCE LORENZ Life Sciences Group

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2012 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.